Your Input: | |||||
C3Y0Y7_BRAFL | Cbl-PTB domain-containing protein. (233 aa) | ||||
C3Y0R6_BRAFL | Uncharacterized protein. (624 aa) | ||||
C3Y0B3_BRAFL | RING-type domain-containing protein. (548 aa) | ||||
C3XZS1_BRAFL | RING-CH-type domain-containing protein. (297 aa) | ||||
C3XZ04_BRAFL | Uncharacterized protein. (358 aa) | ||||
C3XYY3_BRAFL | Uncharacterized protein. (195 aa) | ||||
C3XY68_BRAFL | Uncharacterized protein. (231 aa) | ||||
C3XXN1_BRAFL | HECT domain-containing protein. (1032 aa) | ||||
C3XXN0_BRAFL | RING-type domain-containing protein. (111 aa) | ||||
C3XXM3_BRAFL | Pep3_Vps18 domain-containing protein. (986 aa) | ||||
C3ZAG0_BRAFL | RBR-type E3 ubiquitin transferase. (224 aa) | ||||
C3ZAS2_BRAFL | Uncharacterized protein. (1711 aa) | ||||
C3ZB62_BRAFL | B box-type domain-containing protein. (603 aa) | ||||
C3ZBL6_BRAFL | Uncharacterized protein. (894 aa) | ||||
C3ZBV3_BRAFL | F-box domain-containing protein. (660 aa) | ||||
C3ZC02_BRAFL | Uncharacterized protein. (257 aa) | ||||
C3ZCP7_BRAFL | RING-type domain-containing protein. (150 aa) | ||||
C3ZDH2_BRAFL | RING-type domain-containing protein. (426 aa) | ||||
C3ZDH3_BRAFL | RING-type domain-containing protein. (861 aa) | ||||
C3ZDU4_BRAFL | Uncharacterized protein. (412 aa) | ||||
C3ZDY2_BRAFL | CULLIN_2 domain-containing protein; Belongs to the cullin family. (753 aa) | ||||
C3ZE69_BRAFL | Uncharacterized protein. (250 aa) | ||||
C3ZFJ3_BRAFL | Uncharacterized protein. (463 aa) | ||||
C3ZGC4_BRAFL | Uncharacterized protein. (409 aa) | ||||
C3ZGQ7_BRAFL | RBR-type E3 ubiquitin transferase. (486 aa) | ||||
C3ZH16_BRAFL | Uncharacterized protein. (473 aa) | ||||
C3ZHL3_BRAFL | E3 ubiquitin-protein ligase; Ubiquitin ligase protein which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N- terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. (1427 aa) | ||||
C3ZHL9_BRAFL | E3 ubiquitin-protein ligase; Ubiquitin ligase protein which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N- terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. (372 aa) | ||||
C3ZHM0_BRAFL | E3 ubiquitin-protein ligase; Ubiquitin ligase protein which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N- terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. (487 aa) | ||||
C3ZHP6_BRAFL | NHR domain-containing protein. (118 aa) | ||||
C3ZHP7_BRAFL | NHR domain-containing protein. (122 aa) | ||||
C3ZHY2_BRAFL | UBR-type domain-containing protein. (4564 aa) | ||||
C3ZHY5_BRAFL | SAM domain-containing protein. (438 aa) | ||||
C3ZIC8_BRAFL | Pentaxin. (167 aa) | ||||
C3ZIC9_BRAFL | Pentaxin. (170 aa) | ||||
C3ZJD4_BRAFL | Uncharacterized protein. (436 aa) | ||||
C3ZJD5_BRAFL | DC_STAMP domain-containing protein. (101 aa) | ||||
C3ZJD6_BRAFL | DC_STAMP domain-containing protein. (161 aa) | ||||
C3ZJI4_BRAFL | Uncharacterized protein. (669 aa) | ||||
C3ZJT4_BRAFL | Uncharacterized protein. (214 aa) | ||||
C3ZKL5_BRAFL | Uncharacterized protein. (214 aa) | ||||
C3ZKR5_BRAFL | Uncharacterized protein. (702 aa) | ||||
C3ZKW7_BRAFL | RING-type domain-containing protein. (371 aa) | ||||
C3ZMD7_BRAFL | HECT domain-containing protein. (567 aa) | ||||
C3ZMZ1_BRAFL | Uncharacterized protein. (391 aa) | ||||
C3ZN65_BRAFL | Uncharacterized protein. (147 aa) | ||||
C3ZPC6_BRAFL | RING-type domain-containing protein. (350 aa) | ||||
C3ZPR3_BRAFL | Uncharacterized protein. (193 aa) | ||||
C3ZPR6_BRAFL | Uncharacterized protein. (236 aa) | ||||
C3ZQ24_BRAFL | Uncharacterized protein. (235 aa) | ||||
C3ZQC7_BRAFL | Uncharacterized protein. (424 aa) | ||||
C3ZR28_BRAFL | C2 domain-containing protein. (1419 aa) | ||||
C3ZRQ6_BRAFL | RING-type domain-containing protein. (178 aa) | ||||
C3ZS25_BRAFL | Uncharacterized protein. (2721 aa) | ||||
C3ZSA6_BRAFL | Uncharacterized protein. (219 aa) | ||||
C3ZSF6_BRAFL | NHR domain-containing protein. (102 aa) | ||||
C3ZSF7_BRAFL | NHR domain-containing protein. (159 aa) | ||||
C3ZSF8_BRAFL | Uncharacterized protein. (1202 aa) | ||||
C3ZSZ2_BRAFL | RING-type domain-containing protein. (101 aa) | ||||
C3ZT13_BRAFL | Uncharacterized protein. (238 aa) | ||||
C3ZT14_BRAFL | RING-type domain-containing protein. (3938 aa) | ||||
C3ZT15_BRAFL | Uncharacterized protein. (172 aa) | ||||
C3ZT19_BRAFL | Uncharacterized protein. (4660 aa) | ||||
C3ZTE3_BRAFL | Uncharacterized protein. (1290 aa) | ||||
C3ZTZ5_BRAFL | RING-type domain-containing protein. (685 aa) | ||||
C3ZUG9_BRAFL | Uncharacterized protein; Belongs to the ubiquitin-conjugating enzyme family. (201 aa) | ||||
C3ZVS4_BRAFL | Uncharacterized protein. (474 aa) | ||||
C3ZVV7_BRAFL | Uncharacterized protein. (712 aa) | ||||
C3ZWH0_BRAFL | RING-type domain-containing protein. (158 aa) | ||||
C3ZWX4_BRAFL | Uncharacterized protein. (4251 aa) | ||||
C3ZX62_BRAFL | Uncharacterized protein. (240 aa) | ||||
C3XS65_BRAFL | Uncharacterized protein. (2181 aa) | ||||
C3XRW0_BRAFL | Uncharacterized protein. (208 aa) | ||||
C3XRV9_BRAFL | Uncharacterized protein. (622 aa) | ||||
C3XRV1_BRAFL | E3 ubiquitin-protein ligase; Ubiquitin ligase protein which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N- terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. (1679 aa) | ||||
C3XQD9_BRAFL | Uncharacterized protein. (1044 aa) | ||||
C3YEQ2_BRAFL | RBR-type E3 ubiquitin transferase. (728 aa) | ||||
C3YEQ7_BRAFL | Uncharacterized protein. (504 aa) | ||||
C3YEX1_BRAFL | RING-type domain-containing protein. (78 aa) | ||||
C3YFB3_BRAFL | Uncharacterized protein. (630 aa) | ||||
C3YFD0_BRAFL | Uncharacterized protein. (574 aa) | ||||
C3YG77_BRAFL | Uncharacterized protein. (832 aa) | ||||
C3YGJ4_BRAFL | F-box domain-containing protein. (320 aa) | ||||
C3YH64_BRAFL | Uncharacterized protein. (1645 aa) | ||||
C3YHE8_BRAFL | RING-type domain-containing protein. (446 aa) | ||||
C3YHH3_BRAFL | Uncharacterized protein. (283 aa) | ||||
C3YI23_BRAFL | Uncharacterized protein. (203 aa) | ||||
C3YI94_BRAFL | Uncharacterized protein. (101 aa) | ||||
C3YJ40_BRAFL | CTLH domain-containing protein. (467 aa) | ||||
C3YJ68_BRAFL | LisH domain-containing protein. (300 aa) | ||||
C3YJ83_BRAFL | RING-type domain-containing protein. (180 aa) | ||||
C3YJB1_BRAFL | Uncharacterized protein. (783 aa) | ||||
C3YCK6_BRAFL | HECT domain-containing protein. (1069 aa) | ||||
C3YCK7_BRAFL | HECT domain-containing protein. (344 aa) | ||||
C3YCK8_BRAFL | Uncharacterized protein. (681 aa) | ||||
C3YCM0_BRAFL | F-box domain-containing protein. (317 aa) | ||||
C3YCS5_BRAFL | Uncharacterized protein. (692 aa) | ||||
C3YCT7_BRAFL | RING-CH-type domain-containing protein. (282 aa) | ||||
C3YD20_BRAFL | Uncharacterized protein. (528 aa) | ||||
C3YD25_BRAFL | RING-type domain-containing protein. (171 aa) | ||||
C3YDJ4_BRAFL | RING-type domain-containing protein. (299 aa) | ||||
C3YEG8_BRAFL | NHR domain-containing protein. (168 aa) | ||||
C3YEP0_BRAFL | Uncharacterized protein. (161 aa) | ||||
C3YJE2_BRAFL | Uncharacterized protein. (234 aa) | ||||
C3YCH7_BRAFL | RING-type domain-containing protein. (350 aa) | ||||
C3ZX96_BRAFL | C2 domain-containing protein. (246 aa) | ||||
C3ZX97_BRAFL | HECT domain-containing protein. (599 aa) | ||||
C3ZXC7_BRAFL | RING-type domain-containing protein. (518 aa) | ||||
C3ZXF9_BRAFL | HECT domain-containing protein. (780 aa) | ||||
C3ZXX3_BRAFL | RING-type domain-containing protein. (742 aa) | ||||
C3ZYG5_BRAFL | Uncharacterized protein. (684 aa) | ||||
C3ZZ26_BRAFL | RING-type domain-containing protein. (619 aa) | ||||
C3ZZC4_BRAFL | RING-type domain-containing protein. (288 aa) | ||||
C4A092_BRAFL | Uncharacterized protein. (288 aa) | ||||
C4A0R1_BRAFL | Uncharacterized protein. (251 aa) | ||||
C4A0R2_BRAFL | NHR domain-containing protein. (87 aa) | ||||
C4A0Z9_BRAFL | Uncharacterized protein. (203 aa) | ||||
C4A113_BRAFL | HECT domain-containing protein. (384 aa) | ||||
C3YK34_BRAFL | Uncharacterized protein. (2326 aa) | ||||
C3YK37_BRAFL | Uncharacterized protein. (305 aa) | ||||
C3YK98_BRAFL | Uncharacterized protein. (219 aa) | ||||
C3YKV1_BRAFL | RING-type domain-containing protein. (894 aa) | ||||
C3YLJ2_BRAFL | HECT domain-containing protein. (1535 aa) | ||||
C3YLJ3_BRAFL | Uncharacterized protein. (1297 aa) | ||||
C3YLR5_BRAFL | Uncharacterized protein. (451 aa) | ||||
C3YM09_BRAFL | RING-type domain-containing protein. (262 aa) | ||||
C3YM32_BRAFL | RING-type domain-containing protein. (218 aa) | ||||
C3YM33_BRAFL | RING-type domain-containing protein. (172 aa) | ||||
C3YMI5_BRAFL | Uncharacterized protein. (482 aa) | ||||
C3YMU7_BRAFL | Uncharacterized protein. (151 aa) | ||||
C3YNK1_BRAFL | Uncharacterized protein. (242 aa) | ||||
C3YP84_BRAFL | Uncharacterized protein. (469 aa) | ||||
C3YPE6_BRAFL | Uncharacterized protein. (245 aa) | ||||
C3YPM1_BRAFL | RBR-type E3 ubiquitin transferase. (389 aa) | ||||
C3YPX8_BRAFL | Uncharacterized protein. (287 aa) | ||||
C3YQ01_BRAFL | RING-type domain-containing protein. (267 aa) | ||||
C3YRB7_BRAFL | Uncharacterized protein. (505 aa) | ||||
C3YRC2_BRAFL | Uncharacterized protein. (508 aa) | ||||
C3YRQ4_BRAFL | RING-type domain-containing protein. (319 aa) | ||||
C3YRW4_BRAFL | RING-type domain-containing protein. (190 aa) | ||||
C3YRW5_BRAFL | DTC domain-containing protein. (153 aa) | ||||
C3YRW8_BRAFL | DTC domain-containing protein. (168 aa) | ||||
C3YRX1_BRAFL | DTC domain-containing protein. (152 aa) | ||||
C3YRX3_BRAFL | DTC domain-containing protein. (141 aa) | ||||
C3YRX9_BRAFL | DTC domain-containing protein. (181 aa) | ||||
C3YS04_BRAFL | Macro domain-containing protein. (178 aa) | ||||
C3YS05_BRAFL | RING-type domain-containing protein. (188 aa) | ||||
C3YS13_BRAFL | RING-type domain-containing protein. (191 aa) | ||||
C3YS35_BRAFL | RING-type domain-containing protein. (193 aa) | ||||
C3YSZ8_BRAFL | Uncharacterized protein. (779 aa) | ||||
C3YT30_BRAFL | RING-type domain-containing protein. (145 aa) | ||||
C3YT44_BRAFL | Uncharacterized protein. (373 aa) | ||||
C3YT94_BRAFL | Uncharacterized protein. (227 aa) | ||||
C3YTH7_BRAFL | Uncharacterized protein. (760 aa) | ||||
C3YTI1_BRAFL | Uncharacterized protein. (766 aa) | ||||
C3YTI5_BRAFL | Uncharacterized protein. (188 aa) | ||||
C3YTN8_BRAFL | RING-type domain-containing protein. (200 aa) | ||||
C3YUP3_BRAFL | Uncharacterized protein. (1150 aa) | ||||
C3YUP5_BRAFL | RING-type domain-containing protein. (184 aa) | ||||
C3YUP6_BRAFL | Uncharacterized protein. (609 aa) | ||||
C3YUP7_BRAFL | Uncharacterized protein. (358 aa) | ||||
C3YVA2_BRAFL | RING-CH-type domain-containing protein. (219 aa) | ||||
C3YVM0_BRAFL | SAP domain-containing protein. (299 aa) | ||||
C3YVN0_BRAFL | Uncharacterized protein. (511 aa) | ||||
C3YVP0_BRAFL | ZNRF_3_ecto domain-containing protein. (114 aa) | ||||
C3YVP1_BRAFL | Uncharacterized protein. (57 aa) | ||||
C3YW04_BRAFL | Uncharacterized protein. (684 aa) | ||||
C3YWC4_BRAFL | Uncharacterized protein. (704 aa) | ||||
C3YWQ1_BRAFL | Uncharacterized protein. (915 aa) | ||||
C3YX01_BRAFL | Uncharacterized protein. (223 aa) | ||||
C3YX02_BRAFL | Uncharacterized protein. (217 aa) | ||||
C3YXY3_BRAFL | Uncharacterized protein. (377 aa) | ||||
C3YY01_BRAFL | HECT domain-containing protein. (126 aa) | ||||
C3YY09_BRAFL | Uncharacterized protein. (939 aa) | ||||
C3YY73_BRAFL | Uncharacterized protein. (66 aa) | ||||
C3YYC2_BRAFL | RING-type domain-containing protein. (102 aa) | ||||
C3YZI6_BRAFL | RBR-type E3 ubiquitin transferase. (397 aa) | ||||
C3YZL0_BRAFL | Uncharacterized protein. (240 aa) | ||||
C3YZM1_BRAFL | Uncharacterized protein. (361 aa) | ||||
C3YZN3_BRAFL | Uncharacterized protein. (728 aa) | ||||
C3Z059_BRAFL | Uncharacterized protein. (341 aa) | ||||
C3Z0C4_BRAFL | Uncharacterized protein. (317 aa) | ||||
C3Z0Z7_BRAFL | Uncharacterized protein. (209 aa) | ||||
C3Z1H5_BRAFL | SEFIR domain-containing protein. (163 aa) | ||||
C3Z1H6_BRAFL | SEFIR domain-containing protein. (238 aa) | ||||
C3Z291_BRAFL | RING-type domain-containing protein. (668 aa) | ||||
C3Z3L1_BRAFL | Uncharacterized protein. (189 aa) | ||||
C3Z3S7_BRAFL | NHR domain-containing protein. (155 aa) | ||||
C3Z3T6_BRAFL | UBR-type domain-containing protein. (415 aa) | ||||
C3Z427_BRAFL | FYVE-type domain-containing protein. (325 aa) | ||||
C3Z454_BRAFL | WD_REPEATS_REGION domain-containing protein. (224 aa) | ||||
C3Z455_BRAFL | Uncharacterized protein. (180 aa) | ||||
C3Z485_BRAFL | Uncharacterized protein. (498 aa) | ||||
C3Z490_BRAFL | RING-type domain-containing protein. (696 aa) | ||||
C3Z4A3_BRAFL | Uncharacterized protein. (469 aa) | ||||
C3Z4V7_BRAFL | Uncharacterized protein. (674 aa) | ||||
C3Z502_BRAFL | E3 ubiquitin-protein ligase parkin; Functions within a multiprotein E3 ubiquitin ligase complex, catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins; Belongs to the RBR family. Parkin subfamily. (434 aa) | ||||
C3Z538_BRAFL | RING-CH-type domain-containing protein. (555 aa) | ||||
C3Z5C5_BRAFL | HECT domain-containing protein. (1015 aa) | ||||
C3Z6Y3_BRAFL | UBIQUITIN_CONJUGAT_2 domain-containing protein. (1160 aa) | ||||
C3Z7Q3_BRAFL | Uncharacterized protein. (852 aa) | ||||
C3Z7Q4_BRAFL | RING-type domain-containing protein. (227 aa) | ||||
C3Z7Q5_BRAFL | Uncharacterized protein. (184 aa) | ||||
C3Z7U5_BRAFL | Uncharacterized protein. (427 aa) | ||||
C3Z7U6_BRAFL | HECT domain-containing protein. (341 aa) | ||||
C3Z887_BRAFL | CXC domain-containing protein. (253 aa) | ||||
C3Z896_BRAFL | Uncharacterized protein. (267 aa) | ||||
C3Z994_BRAFL | Uncharacterized protein. (557 aa) | ||||
C3Z9J5_BRAFL | Uncharacterized protein. (235 aa) | ||||
C3XXD5_BRAFL | Uncharacterized protein. (707 aa) | ||||
C3XWU3_BRAFL | Uncharacterized protein. (337 aa) | ||||
C3XWB8_BRAFL | PA domain-containing protein. (248 aa) | ||||
C3XWA3_BRAFL | Uncharacterized protein. (685 aa) | ||||
C3XW57_BRAFL | Uncharacterized protein. (1015 aa) | ||||
C3XVY8_BRAFL | E3 ubiquitin-protein ligase parkin; Functions within a multiprotein E3 ubiquitin ligase complex, catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins; Belongs to the RBR family. Parkin subfamily. (414 aa) | ||||
C3XVI2_BRAFL | E3 ubiquitin protein ligase. (655 aa) | ||||
C3XVI0_BRAFL | E3 ubiquitin protein ligase. (243 aa) | ||||
C3XUA6_BRAFL | Ufd2P_core domain-containing protein. (234 aa) | ||||
C3XU51_BRAFL | Uncharacterized protein. (213 aa) | ||||
C3XU40_BRAFL | Uncharacterized protein. (2155 aa) | ||||
C3XTS8_BRAFL | Uncharacterized protein. (708 aa) | ||||
C3XTG2_BRAFL | RBR-type E3 ubiquitin transferase. (126 aa) | ||||
C3XTF9_BRAFL | Uncharacterized protein. (236 aa) | ||||
C3XTB5_BRAFL | Uncharacterized protein. (932 aa) | ||||
C3XSY7_BRAFL | Uncharacterized protein. (614 aa) | ||||
C3XSG6_BRAFL | Uncharacterized protein. (221 aa) | ||||
C3YCH6_BRAFL | Uncharacterized protein. (152 aa) | ||||
C3YCB4_BRAFL | C2H2-type domain-containing protein. (977 aa) | ||||
C3YBG7_BRAFL | RING-type domain-containing protein. (89 aa) | ||||
C3YBE1_BRAFL | Uncharacterized protein. (502 aa) | ||||
C3YAN8_BRAFL | Uncharacterized protein. (238 aa) | ||||
C3YAM7_BRAFL | Uncharacterized protein. (692 aa) | ||||
C3YAH6_BRAFL | Uncharacterized protein. (430 aa) | ||||
C3Y9I2_BRAFL | Uncharacterized protein. (1831 aa) | ||||
C3Y9B4_BRAFL | RING-type domain-containing protein. (1001 aa) | ||||
C3Y9A7_BRAFL | Uncharacterized protein. (1204 aa) | ||||
C3Y954_BRAFL | HECT domain-containing protein. (1086 aa) | ||||
C3Y922_BRAFL | Uncharacterized protein. (546 aa) | ||||
C3Y8Z4_BRAFL | Uncharacterized protein. (132 aa) | ||||
C3Y8U1_BRAFL | RING-type domain-containing protein. (178 aa) | ||||
C3Y7W6_BRAFL | Uncharacterized protein. (219 aa) | ||||
C3Y7M0_BRAFL | Uncharacterized protein. (371 aa) | ||||
C3Y700_BRAFL | HECT domain-containing protein. (503 aa) | ||||
C3Y6Z9_BRAFL | HECT domain-containing protein. (269 aa) | ||||
C3Y6Z2_BRAFL | HECT domain-containing protein. (467 aa) | ||||
C3Y6Z1_BRAFL | HECT domain-containing protein. (121 aa) | ||||
C3Y6Z0_BRAFL | HECT domain-containing protein. (161 aa) | ||||
C3Y6P7_BRAFL | RING-type domain-containing protein. (581 aa) | ||||
C3Y6P3_BRAFL | Uncharacterized protein. (728 aa) | ||||
C3Y6L1_BRAFL | Uncharacterized protein. (310 aa) | ||||
C3Y6H6_BRAFL | RING-type domain-containing protein. (581 aa) | ||||
C3Y6H5_BRAFL | RING-type domain-containing protein. (449 aa) | ||||
C3Y611_BRAFL | Uncharacterized protein. (557 aa) | ||||
C3Y604_BRAFL | Uncharacterized protein. (448 aa) | ||||
C3Y5X0_BRAFL | Macro domain-containing protein. (970 aa) | ||||
C3Y5W8_BRAFL | Uncharacterized protein. (635 aa) | ||||
C3Y5S1_BRAFL | RING-type domain-containing protein. (118 aa) | ||||
C3Y5Q2_BRAFL | Uncharacterized protein. (1122 aa) | ||||
C3Y5M1_BRAFL | zf-NOSIP domain-containing protein. (272 aa) | ||||
C3Y416_BRAFL | DTC domain-containing protein. (154 aa) | ||||
BTRCa | Beta-transducin repeat containing protein, isoform a. (296 aa) | ||||
C3Y3Q8_BRAFL | Uncharacterized protein. (1459 aa) | ||||
C3Y3J4_BRAFL | RING-type domain-containing protein. (198 aa) | ||||
C3Y3J1_BRAFL | RING-type domain-containing protein. (180 aa) | ||||
C3Y3I9_BRAFL | RING-type domain-containing protein. (180 aa) | ||||
C3Y3H9_BRAFL | RING-type domain-containing protein. (841 aa) | ||||
C3Y345_BRAFL | RING-type domain-containing protein. (582 aa) | ||||
C3Y342_BRAFL | Uncharacterized protein. (584 aa) | ||||
C3Y2Q0_BRAFL | Uncharacterized protein. (119 aa) | ||||
C3Y1L1_BRAFL | Uncharacterized protein. (205 aa) | ||||
C3Y1B9_BRAFL | zf-RING-like domain-containing protein. (281 aa) | ||||
C3Y171_BRAFL | Uncharacterized protein. (144 aa) | ||||
C3Y170_BRAFL | RBR-type E3 ubiquitin transferase. (299 aa) | ||||
C3Y155_BRAFL | RING-type domain-containing protein. (834 aa) | ||||
C3Y132_BRAFL | E3 ubiquitin-protein ligase; E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of target proteins. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. (272 aa) |